More recent studies from our groups have shown methylation in the PLK2 CpG island in other haematological malignancies including multiple myeloma [5], acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) [6]. The gene discussed is PLK2; the disease is myelodysplastic syndrome.